• Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
      • dxn1 digitalABST
    • Oncology
      • gSeek Onco+
      • gSeek Bone
      • gSeek Brain
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • gSeek Kidney
      • gSeek Lung
      • gSeek Liver
      • gSeek Leukemia
      • gSeek Pancreas
      • gSeek Prostate
      • GSeek Carrier Screening
    • Transplant
      • gSeek Transplant High Resolution
      • gSeek Transplant Low Resolution
    • Pediatrics
      • GSeek Newborn Screening
      • gSeek Rare Diseases
    • Mother & Baby Wellness
      • gScan NIPT
      • gScan NIPT+
      • gScan PGD
      • gScan PGS
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us

Credence Genomics Credence Genomics

Credence Genomics

  • Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
      • dxn1 digitalABST
    • Oncology
      • gSeek Onco+
      • gSeek Bone
      • gSeek Brain
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • gSeek Kidney
      • gSeek Lung
      • gSeek Liver
      • gSeek Leukemia
      • gSeek Pancreas
      • gSeek Prostate
      • GSeek Carrier Screening
    • Transplant
      • gSeek Transplant High Resolution
      • gSeek Transplant Low Resolution
    • Pediatrics
      • GSeek Newborn Screening
      • gSeek Rare Diseases
    • Mother & Baby Wellness
      • gScan NIPT
      • gScan NIPT+
      • gScan PGD
      • gScan PGS
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us
සිංහල
தமிழ்

Introducing FungiFast

FungiFast by Credence Genomics is a rapid, accurate testing method specifically designed to identify fungal infections and contaminations in clinical as well as industrial environments.  The test detects and profiles the entire spectrum of known fungi present in the patient / industrial samples while providing the relative abundances of each species of fungi present in the sample within 48 hours.

FungiFast for a multitude of industries

 Healthcare

  • Superficial, Subcutaneous and systemic fungal infections
  • Opportunistic fungal infections in immunocompromised, transplant or parenterally fed patients or in Individuals on corticosteroid treatment or heavy antibiotic therapy

Industry

Fungal contaminations in food and beverages / agricultural products / dairy products / pharmaceutical products / cosmetic and personal care products

  • Environmental and marine microbe profiling
  • Bioremediation efficiency testing
  • Veterinary care

What is FungiFast

Eliminating the need of culturing of samples, this entirely culture-independent procedure provides a key to deeper analysis of the fungal samples.  In contrast to conventional biological processes that took over a week for identification testing performed on the basis of external appearance and spore morphology (which is often misidentified unless performed by highly skilled technical personnel), FungiFast utilizes massively parallel sequencing of fungal DNA. This test acts as an ideal option in many scenarios, at different levels.

With unmatched turnaround time (48 hours), accuracy and sensitivity,  FungiFast is rapidly taking over the conventional techniques of fungal identification. It’s time to put aside observation dependent conservative culture processes of fungal identification.

FungiFast is a test based on a simple workflow

  • DNA extraction from test sample (Blood / FFPE tissue / Industrial samples)
  • DNA amplification with primers specific to ITS region
  • Library preparation
  • Template preparation
  • Sequencing
  • Data analysis
  • Reporting

Key points

  • Fungifast provides accurate identification with fast turnaround time
  • Invaluable service to healthcare and industry
  • Fungifast moves away from conventional techniques
  • Quicker, less expensive, more accurate testing
  • Better recovery for patients and reduced downtime in industry

Did you know?

Our bodies harbour a total of Ten Thousand Trillion microbial cells, which exceeds the total number of our own body cells. In addition, we inhale and consume an entire load of microbes each day. That makes us walking Petri dishes with shoes! Some of these microbes can be extremely pathogenic and act as causative agents of life-threatening diseases.

Credence BactFast

Non-Invasive GScan (NIPT)

Hotline

+94 705551990

011 2890687 / 011 2818370

info@credencegenomics.com

12-3/2 Sunethra Devi Road,
Kohuwala, Sri Lanka.

Call me back

Please fill out this form if you would want us to call you back.

captcha

Latest News Feed

https://www.credencegenomics.com/news/apollo-india-launches-dna-based-diagnostics-with-sri-lankas-credence-genomics/

Apollo India launches DNA based diagnostics with Sri Lanka’s Credence Genomics

December 3, 2017

Chennai – The Apollo Hospitals Group, India’s largest integrated... Read More

https://www.credencegenomics.com/news/eye-live-interview-dr-vaz-santosh-gnanam-ceo-director-credence-genomics/

EYE LIVE INTERVIEW DR. VAZ SANTOSH GNANAM – CEO / DIRECTOR – CREDENCE GENOMICS

December 2, 2017

Eye Live morning TV show interviewing Dr. Vaz Santosh... Read More

https://www.credencegenomics.com/news/bmc-infectious-diseases-publishes-credence-rid-bactfast-fungifast/

BMC Infectious Diseases publishes Credence RID, Bactfast & Fungifast

December 2, 2017

Credence Genomics Ltd., Sri Lanka’s premier specialised DNA diagnostics... Read More

View All

© Credence Genomics 2023. BenWorldwide | Feedback

Thank you

Your inquiry has been received.

Close